Dali Pharmaceutical Co. Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 48.999 million compared to CNY 44.549 million a year ago. Operating income was CNY 284,865.51 compared to CNY 154,741.73 a year ago. Net income was CNY 189,613.98 compared to net loss of CNY 1.129 million a year ago. Basic earnings per share from continuing operations was CNY 0.0009 compared to basic loss per share from continuing operations of CNY 0.0051 a year ago.